Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tristram D Bahnson

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 31, 2022
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANAKristi H Monahan, T Jared Bunch, Daniel B Mark, et al.
Journal of the American College of Cardiology|June 27, 2020
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA TrialJeanne E Poole, Tristram D Bahnson, Kristi H Monahan, et al.
American Heart Journal|May 15, 2018
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and DesignDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
Circulation|January 27, 2021
Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA TrialAndrea M Russo, Emily P Zeitler, Anna Giczewska, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDaniel B Mark, Kevin J Anstrom, Shubin Sheng, et al.
JACC. Clinical Electrophysiology|March 31, 2018
Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-AnalysisDaniel J Friedman, Eric W Black-Maier, Adam S Barnett, et al.
American Heart Journal|February 2, 2024
Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trialRiccardo Cappato, Daniel B Mark, Adam P Silverstein, et al.
Journal of the American Heart Association|January 23, 2023
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA TrialEmily P Zeitler, Yanhong Li, Adam P Silverstein, et al.
Heart Rhythm|April 2, 2018
Dofetilide dose reductions and discontinuations in women compared with menSean D Pokorney, Debbie C Yen, Kristen B Campbell, et al.
The American Journal of Cardiology|December 8, 2009
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery diseaseBrett D Atwater, Vivian P Thompson, Richard N Vest, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 31, 2022
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANAKristi H Monahan, T Jared Bunch, Daniel B Mark, et al.
Journal of the American College of Cardiology|June 27, 2020
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA TrialJeanne E Poole, Tristram D Bahnson, Kristi H Monahan, et al.
American Heart Journal|May 15, 2018
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and DesignDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
Circulation|January 27, 2021
Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA TrialAndrea M Russo, Emily P Zeitler, Anna Giczewska, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDaniel B Mark, Kevin J Anstrom, Shubin Sheng, et al.
JACC. Clinical Electrophysiology|March 31, 2018
Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-AnalysisDaniel J Friedman, Eric W Black-Maier, Adam S Barnett, et al.
American Heart Journal|February 2, 2024
Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trialRiccardo Cappato, Daniel B Mark, Adam P Silverstein, et al.
Journal of the American Heart Association|January 23, 2023
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA TrialEmily P Zeitler, Yanhong Li, Adam P Silverstein, et al.
Heart Rhythm|April 2, 2018
Dofetilide dose reductions and discontinuations in women compared with menSean D Pokorney, Debbie C Yen, Kristen B Campbell, et al.
The American Journal of Cardiology|December 8, 2009
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery diseaseBrett D Atwater, Vivian P Thompson, Richard N Vest, et al.
Pageof 5